Non-Invasive Hemoglobin Monitoring of Women Undergoing Cesarean Delivery

NCT02275507 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-12-04

No results posted yet for this study

Summary

The purpose of this study is to determine the normal hemoglobin curve during cesarean delivery and for the first 24 hours after surgery to aid in the creation of an algorithm to detect life-threatening bleeding earlier.

Conditions

  • Complications of Pregnancy, Childbirth and the Puerperium

Interventions

DEVICE

Masimo Rainbow Sensor

Non-Invasive Hemoglobin Measurement

Sponsors & Collaborators

Principal Investigators

  • Joseph Chappelle, MD · Stony Brook University Hospital

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-10-15
Primary Completion
2016-10-30
Completion
2016-10-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02275507 on ClinicalTrials.gov